Ticker
NKTRCompany Name
NEKTAR THERAPEUTICSSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -184.91M | $ -13.13 | 1 | 14.09M |
3/31/2025 | $ -176.87M | $ -12.58 | 1 | 14.06M |
12/31/2024 | $ -175.71M | $ -12.82 | 1 | 13.71M |
9/30/2024 | $ -176.57M | $ -12.66 | 1 | 13.95M |
6/30/2024 | $ -174.76M | $ -12.55 | 1 | 13.92M |
3/31/2024 | $ -188.58M | $ -14.52 | 1 | 12.98M |
12/31/2023 | $ -192.61M | $ -15.21 | 1 | 12.67M |
9/30/2023 | $ -203.26M | $ -16.01 | 1 | 12.69M |
6/30/2023 | $ -244.03M | $ -19.3 | 1 | 12.64M |
3/31/2023 | $ -267.5M | $ -21.24 | 1 | 12.59M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / (Shares WA * Share Factor)
(=) OCFPS
OCFPS for NEKTAR THERAPEUTICS is calculated as follows: CF - Operations [ $ -339.88M ] / (Shares WA [ 11.94M ] * Share Factor [ 1 ])
(=) OCFPS [ $ -28.47 ]
Minimum
Mar 31, 2022
Maximum
Jun 30, 2024
Average
Median
filtered constituents | 3.79K |
---|---|
min | $ -9.04 |
max | $ 11.43 |
average | $ 1.65 |
median | $ 0.89 |
std | $ 3.42 |